IONS - CIK 0000874015
The table below shows IONIS PHARMACEUTICALS INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $173.38M | $338.34M | $297.30M | $264.19M | $334.61M | $293.99M |
| Short-term investments | $1.75B | $1.90B | $1.99B | $1.88B | $2.15B | $1.78B |
| Receivables | - | - | - | - | - | - |
| Inventory | $5.56M | $10.47M | $8.48M | $11.50M | $28.45M | $28.72M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $2.94B |
| $2.52B |
| $2.58B |
| $2.42B |
| $2.71B |
| $2.33B |
| Property, plant & equipment | $142.40M | $106.12M | $111.95M | $102.92M | $82.50M | $75.90M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $3.45B | $3.03B | $2.99B | $2.81B | $3.08B | $2.69B |
| Accounts payable | $26.03M | $14.33M | $22.80M | $17.46M | $9.05M | $9.24M |
| Total current liabilities | $716.59M | $903.46M | $897.24M | $250.29M | $304.57M | $306.16M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $2.96B | $2.42B | $2.35B | $2.34B | $2.42B | $2.43B |
| Retained earnings | -$2.72B | -$2.40B | -$2.27B | -$2.40B | -$2.15B | -$2.00B |
| Total equity | $491.41M | $617.97M | $631.72M | $475.73M | $662.47M | $263.70M |